ALNY icon

Alnylam Pharmaceuticals

418 hedge funds and large institutions have $16.5B invested in Alnylam Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 131 increasing their positions, 159 reducing their positions, and 68 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

18% less repeat investments, than reductions

Existing positions increased: 131 | Existing positions reduced: 159

21% less first-time investments, than exits

New positions opened: 54 | Existing positions closed: 68

25% less funds holding in top 10

Funds holding in top 10: 86 (-2)

Holders
418
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$486M
Puts
$346M
Net Calls
Net Calls Change

Top Buyers

1 +$626M
2 +$238M
3 +$90.2M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$48.6M
5
Morgan Stanley
Morgan Stanley
New York
+$40.8M

Top Sellers

1 -$251M
2 -$178M
3 -$131M
4
Invesco
Invesco
Georgia
-$117M
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$92.7M
Name Holding Trade Value Shares
Change
Change in
Stake
176
$2.03M
177
$2.01M
178
$1.99M
179
$1.94M
180
$1.93M
181
$1.93M
182
$1.86M
183
$1.81M
184
$1.81M
185
$1.76M
186
$1.75M
187
$1.73M
188
$1.72M
189
$1.7M
190
$1.66M
191
$1.65M
192
$1.61M
193
$1.6M
194
$1.59M
195
$1.59M
196
$1.57M
197
$1.57M
198
$1.57M
199
$1.56M
200
$1.55M